Business·Industry

Stock Investing Is Better Than This Business... Small and Mid-Sized Companies Reap Benefits from KOSPI Rally

Allerman Invested in Samsung, SK Hynix, and KODEX Leverage Last Year As of the closing price on the 4th, unrealized gains alone exceeded 100 billion won KCC Records Over 8 Trillion Won in Unrealized Gains from Long-Term Investment in Samsung C&T

[Edaily Reporter Kim Se-yeon] With the recent stock market boom, an increasing number of small and medium-sized enterprises (SMEs) and mid-sized companies are enjoying massive paper gains from the rising value of their stock holdings rather than from their core businesses. Bedding company Allerman is estimated to have earned over 100 billion won from investments in #SamsungElectronics, #SKHynix, and KODEX Leverage, while building materials company #KCC holds a stake in #SamsungC&T valued at over 9 trillion won.
Allerman’s Levea duvet (left) and the KCC headquarters building. (Photo courtesy of respective companies)

According to the Financial Supervisory Service’s electronic disclosure system on the 4th, Allerman acquired 30,000 shares of Samsung Electronics, 17,132 shares of SK Hynix, and 482,871 shares of KODEX Leverage last year. The company purchased 30,000 shares of Samsung Electronics for 3.263 billion won. Although the unit price per share was only about 108,800 won at the time of acquisition, it has more than tripled to 351,500 won based on today’s closing price. By simple calculation, the current value of the held shares is estimated at approximately 10.5 billion won, with an unrealized gain exceeding 7 billion won.
The investment performance of SK Hynix is even more striking. The 17,132 shares of SK Hynix stock Allerman purchased last year have risen nearly fourfold, from a value of 10.06991 billion won at the time of acquisition to approximately 39.4 billion won on this day. Although the acquisition price per share was only about 587,800 won, SK Hynix’s closing price on this day reached 2,298,000 won.
In particular, it appears that significant returns were also generated from investments in KODEX Leverage. The acquisition cost was 20.14913 billion won, amounting to approximately 41,728 won per share, but the value based on today’s closing price is estimated at approximately 104 billion won. KODEX Leverage’s closing price today was 215,360 won.
Building materials company KCC has created a prime example of a successful long-term investment through its investment in Samsung C&T. The value of the 17.01 million shares of Samsung C&T stock acquired by KCC in 2012 amounts to approximately 9.1 trillion won based on the closing price on that day. The capital gain compared to the initial acquisition cost (1.081115 trillion won) amounts to approximately 8 trillion won. The book value of KCC’s stake in Samsung C&T had already risen significantly to 4.0738 trillion won as of the end of last year. With the upward trend continuing this year, the value has more than doubled compared to the end of last year.
For these companies, the profits generated through investments far exceeded those from their core businesses. Allerman’s operating profit last year was 26.9 billion won, which is only one-fourth of the investment profit (approximately 110 billion won) calculated based on today’s closing price. Similarly, while KCC generates annual operating profits in the range of 300 to 400 billion won, the profit from its long-term investment in Samsung C&T alone amounts to 8 trillion won.
A KCC official stated only that “we are currently reviewing our future plans for managing Samsung C&T shares.”

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02